UNIVERSITY OF IOWA HOSP & CLINICS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $150.1M
- Transactions
- 17,826
- Companies
- 40
- Average per transaction
- $8,423
Who reported the payments
| Pfizer | $18,726,757 |
| Merck | $16,938,868 |
| Novartis | $10,545,646 |
| Amgen | $7,357,566 |
| Regeneron | $4,728,525 |
| AbbVie | $4,621,557 |
| Janssen Research & Development, LLC | $4,282,122 |
| Boston Scientific | $3,711,227 |
| Vertex | $3,351,480 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,324,953 |
| E.r. Squibb & Sons, L.L.C. | $3,232,479 |
| Sarepta Therapeutics, Inc. | $3,113,353 |
| Cochlear Americas | $2,945,703 |
| AstraZeneca | $2,898,463 |
| Novo Nordisk AS | $2,797,992 |
| Gilead | $2,508,724 |
| Med-el Corporation | $2,505,957 |
| Genentech, Inc. | $2,415,867 |
| Eli Lilly | $1,597,526 |
| Sanofi US Services Inc. | $1,527,748 |
| Bristol Myers Squibb | $1,467,856 |
| Genmab U.S., Inc. | $1,370,899 |
| Sanofi | $1,262,067 |
| Edwards Lifesciences | $1,259,409 |
| Spark Therapeutics, Inc. | $1,242,326 |
| Beigene, Ltd. | $1,141,652 |
| Medtronic | $1,065,570 |
| Progenics Pharmaceuticals, Inc. | $1,035,424 |
| Incyte Corporation | $962,173 |
| Intercept Pharmaceuticals, Inc. | $921,195 |
| Zimmer Biomet | $889,167 |
| Boehringer Ingelheim | $834,359 |
| Solventum Corporation | $825,788 |
| Seagen Inc. | $797,257 |
| ZOLL Medical Corporation | $777,870 |
| F. Hoffmann-la Roche AG | $730,966 |
| New York Blood Center, Inc. | $668,157 |
| PTC Therapeutics, Inc. | $664,972 |
| GE HealthCare | $653,599 |
| 3M Company | $638,774 |